A rat model of severe VWD by elimination of the VWF gene using CRISPR/Cas9
Abstract Background Von Willebrand Disease (VWD) is the most common inherited bleeding disorder, caused by quantitative and qualitative changes in von Willebrand factor (VWF). The biology of VWD, studied in canine, porcine, and murine models, differ in species‐specific biology of VWF and the amenabi...
Main Authors: | Jessica Garcia, Veronica H. Flood, Sandra L. Haberichter, Scot A. Fahs, Jeremy G. Mattson, Aron M. Geurts, Mark Zogg, Hartmut Weiler, Qizhen Shi, Robert R. Montgomery |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2020-01-01
|
Series: | Research and Practice in Thrombosis and Haemostasis |
Subjects: | |
Online Access: | https://doi.org/10.1002/rth2.12280 |
Similar Items
-
Pharmacokinetics, Efficacy and Safety of a Plasma-Derived VWF/FVIII Concentrate (Formulation V) in Pediatric Patients with von Willebrand Disease (SWIFTLY-VWD Study)
by: Auerswald G, et al.
Published: (2020-06-01) -
Human plasma-derived FVIII/VWD concentrate (Biostate): a review of experimental and clinical pharmacokinetic, efficacy and safety data
by: Paul Harper, et al.
Published: (2016-04-01) -
Investigating the Genetic Basis of Type 3 of Von Willebrand Disease (VWD)
by: Bowman, MACKENZIE
Published: (2013) -
von Willebrand Disease: The diagnosis and management of this bleeding disorder
by: Basim A. Abd, et al.
Published: (2020-01-01) -
[Cost-minimization analysis of replacement therapy in the treatment of von Willebrand disease]
by: Giancarlo Castaman
Published: (2016-06-01)